Open access
Histone deacetylase activity limits the response to EZH2 inhibition-based therapy in epithelioid sarcoma and is targetable by epigenetic combination
N. Arrighetti
C. Soffientini
V. Zuco
Stefano Percio
L. Cleris
Suzan Abdulrazak Ahmed
Elisa Del Savio
L. Sigalotti
R. Maestro
S. Brich
G. Dagrada
M. Barisella
P. Collini
A. Kentsis
Paul H Huang
A. Gronchi
A. Frezza
S. Stacchiotti
Nadia Zaffaroni
Sandro Pasquali
Biology